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Abstract
 
B cell maturation is a very selective process that requires finely tuned differentiation and sur-
 
vival signals. B cell activation factor from the TNF family
 
 (
 
BAFF) is a TNF family member that
binds to B cells and potentiates B cell receptor (BCR)-mediated proliferation. A role for BAFF
in B cell survival was suggested by the observation of reduced peripheral B cell numbers in
mice treated with reagents blocking BAFF, and high Bcl-2 levels detected in B cells from
BAFF transgenic (Tg) mice. We tested in vitro the survival effect of BAFF on lymphocytes de-
rived from primary and secondary lymphoid organs. BAFF induced survival of a subset of
splenic immature B cells, referred to as transitional type 2 (T2) B cells. BAFF treatment allowed
T2 B cells to survive and differentiate into mature B cells in response to signals through the
BCR. The T2 and the marginal zone (MZ) B cell compartments were particularly enlarged in
BAFF Tg mice. Immature transitional B cells are targets for negative selection, a feature
thought to promote self-tolerance. These findings support a model in which excessive BAFF-
mediated survival of peripheral immature B cells contributes to the emergence and maturation
of autoreactive B cells, skewed towards the MZ compartment. This work provides new clues
on mechanisms regulating B cell maturation and tolerance.
Key words: B cell maturation • autoimmunity • transitional B lymphocyte • spleen • antigen 
receptor
 
Introduction
 
Over the past 30 years, research on B lymphocyte develop-
ment has concentrated on the early stages, in the bone mar-
 
row (BM),
 
1
 
 where lymphoid progenitor cells give rise to
fully committed B lymphocytes after a process of sequential
recombination and assembly of Ig gene components (1).
The BM is also an important site for induction of immune
tolerance, where self-reactive B lymphocytes are elimi-
nated if they encounter membrane-bound self-antigen dur-
ing their development (2–4).
In contrast, little is known about the signals driving the
 
maturation of peripheral immature IgM
 
1
 
 B cells into ma-
ture, recirculating B cells. Several studies have shown that
immature B cells leaving the BM, in contrast to mature B
cells, do not proliferate in response to stimulation of their B
cell receptor (BCR), but rather undergo death by apoptosis
(5). This feature is thought to allow negative selection of
 
emerging autoreactive B cells after encounter with self-
antigen in the periphery (6, 7).
Immature B cells found in the periphery are referred to
as immature transitional B cells to distinguish them from
their BM counterparts (6). The phenotype of transitional B
cells varies from study to study but is generally thought to
feature high levels of surface IgM (IgM
 
hi
 
) and CD24 (heat
stable antigen [HSA]; references 5, 6, 8–10). The lack of a
clear definition of immature transitional B cells may have
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Abbreviations used in this paper:
 
 ANOVA, analysis of variance; BAFF, B
cell activation factor from the TNF family; BCMA, B cell maturation an-
tigen; BCR, B cell receptor; BM, bone marrow; FSC, forward light scat-
ter; HSA, heat stable antigen; MLN, mesenteric LN; MZ, marginal zone;
PI, propidium iodine; PLN, peripheral LN; SSC, side light scatter; T1,
transitional immature B cell type 1; T2, transitional immature B cell type
2; TACI, transmembrane activator and calcium-modulating and cyclo-
philin ligand interactor; Tg, transgenic.
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arisen from possible heterogeneity in this population. This
idea is supported by a recent study demonstrating the exist-
ence of two transitional B cell stages in the spleen. Transi-
tional type 1 (T1) B cells are IgM
 
hi
 
 and negative for IgD
(IgD
 
2
 
), L-selectin (L-selectin
 
2
 
), CD23 (CD23
 
2
 
), and
CD21 low (CD21
 
lo
 
), and transitional type 2 (T2) B cells
are IgM
 
hi
 
, IgD
 
hi
 
, CD21
 
hi
 
, CD23
 
1
 
, and L-selectin
 
1
 
 (11).
Immature B cells leaving the BM are thought to differenti-
ate into T1 B cells before reaching the spleen. B cell matu-
ration is an active process that appears to take place in the
spleen, as T1 B cells do not express L-selectin, preventing
them from homing to LNs, and T2 B cells are only found
in the spleen (11). Adoptive transfer experiments in recom-
bination activating gene (RAG)-2
 
2
 
/
 
2
 
 mice using purified
T1 or T2 B cell subsets have shown that T1 are the precur-
sors for T2 and mature B cells and T2 B cells are the direct
precursors of mature B cells (11). It is still unclear whether
T1 B cells can differentiate directly into mature B cells.
The maturation of B cells through the T1 and T2 stages
depends on signals through the BCR (11–13).
B cell activation factor from the TNF family (BAFF; also
called TNF and apoptosis ligand–related leukocyte-expressed
ligand 1 [TALL-1], TNF homologue that activates apoptosis,
nuclear factor 
 
k
 
B, and c-Jun NH
 
2
 
-terminal kinase [THANK],
B lymphocyte stimulator [BlyS], and zTNF4) is a member
of the TNF family expressed by T cells, monocytes/mac-
rophages, and dendritic cells (14–18). BAFF can be found
both as a membrane-bound factor and as a soluble agent
(14, 17). BAFF specifically binds to B cells and promotes
their proliferation in the presence of anti-
 
m
 
 (14–17). Re-
cently, two known orphan TNF receptor–like molecules,
B cell maturation antigen (BCMA [19, 20]) and trans-
membrane activator and calcium-modulating and cyclo-
philin ligand (CAML) interactor (TACI [21]), were identi-
fied as specific receptors for BAFF (18, 22, 23). Expression
of BCMA is B cell specific (19, 20, 24, 25), whereas that of
TACI can be found on B cells as well as on subsets of
activated T cells (21). Injection of BAFF in normal mice
leads to the disruption of the splenic B and T cell structures
and results in elevated levels of IgM in the serum (17).
BAFF transgenic (Tg) mice have an elevated number of B
lymphocytes in the periphery, secrete various autoantibod-
ies, and develop an SLE-like condition leading to severe
glomerulonephritis (18, 26, 27). The number of marginal
zone (MZ) B cells is increased in BAFF Tg mice (26). In
contrast, B cell development in the BM is not affected by
the BAFF transgene (18, 26, 27). Treatment of normal
mice with blocking soluble BCMA-Ig fusion protein led to
a marked reduction in B cell numbers in the periphery
(22). Treatment of mice with TACI-Ig inhibits T cell–
dependent and –independent immune responses (23), abol-
ishes germinal center formation (28), and was shown to
prevent proteinuria and prolong the life of mice in a model
of SLE (18).
Current information clearly demonstrates that BAFF is a
very important factor controlling several aspects of B cell
biology with the potential to break immune tolerance
when overexpressed. Here we show that, in vitro, BAFF
 
preferentially supports the survival of a subset of immature
(T2) and some MZ B cells found solely in the spleen of
normal mice. The T2 and MZ B cell subsets are enlarged
in BAFF Tg mice, and some survive 72 h in vitro without
exogenous stimuli. Our results suggest that excess survival
signals provided to peripheral immature B cells in BAFF Tg
mice reduce sensitivity of autoreactive B cells to BCR-
mediated negative selection, resulting in autoimmunity. Our
work underscores the importance of BAFF for B cell matu-
ration, immune tolerance, and maintenance of B cell ho-
meostasis.
 
Materials and Methods
 
Mice.
 
Full-length murine BAFF was expressed in Tg mice
using the liver-specific 
 
a
 
1 antitrypsin promoter with the apolipo-
protein (Apo) E enhancer as described previously (26). C57BL/6
and C3H/HeJ mice were purchased from Animal Resource
Center. BAFF Tg mice are maintained as heterozygotes for the
transgene by backcrossing onto C57BL/6 mice. BAFF Tg mice
are screened for the presence of the transgene, both by PCR and
Southern blot analysis using genomic DNA isolated from 2–3-
mm long tail snips. We used mice from two separate lines of
BAFF Tg mice issued after 8–10 backcrossings to C57BL/6. In
experiments including BAFF Tg mice, negative littermates were
used as control. Animals between 6 and 12 mo old were used,
except for experiments including histological procedures for
which younger 3–4-mo-old animals were selected. Animals were
housed under conventional barrier protection and handled in ac-
cordance with the Animal Experimentation and Ethic Commit-
tee, which complies with the Australian code of practice for the
care and use of animals for scientific purposes.
 
Reagents.
 
Flag-tagged soluble human BAFF (amino acids 83–
285) was expressed by 
 
Escherichia coli
 
 and purified as described
previously (14, 22). Human recombinant BAFF was shown to ef-
ficiently stimulate mouse B cells (17, 22). We found that the op-
timal concentration for BAFF in our assays was 2 
 
m
 
g/ml (data not
shown). BAFF was also inactivated by boiling for 30–45 min and
used as control. Polymyxin B and LPS from 
 
E. coli
 
 were obtained
from Sigma-Aldrich and used at a final concentration of 5 and 10
 
m
 
g/ml, respectively. Polyclonal rabbit anti-BAFF serum was ob-
tained from rabbits immunized with human flag-tagged BAFF
(amino acids 83–285) as described previously (14). The serum
collected from bleeds made before immunization of these rabbits
with BAFF was used as control.
 
Preparation and Culture of Lymphocytes.
 
Mice were killed by
cervical dislocation and lymphoid organs were collected under
sterile conditions. Spleen, thymus, and LNs were dissociated by
grinding between frosted glass slides (Menzel-Glaser). Cells from
the BM were collected after flushing mouse femurs with RPMI.
PBLs were isolated by density gradient centrifugation of EDTA-
treated mouse blood over Ficoll-Paque™ PLUS (Amersham
Pharmacia Biotech). Cells were filtered though a 70-
 
m
 
m nylon
cell strainer (Falcon; Becton Dickinson), and erythrocytes were
removed by osmotic lysis with red blood cell lysis solution (8.34
g/liter ammonium chloride, 0.84 g/liter sodium bicarbonate, and
1 mM EDTA, pH 8.0). Cultures were conducted in glutamine-
containing RPMI 1640 supplemented with 10% FCS and 100
U/ml penicillin/streptomycin (Life Technologies). Lymphocytes
(3 
 
3
 
 10
 
6
 
/ml) were routinely stimulated for 72 h in culture with 2
 
m
 
g/ml recombinant soluble human flag-tagged BAFF. Polyclonal
rabbit anti-BAFF and rabbit control sera were used at the final
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concentration of 5%. Specific goat anti–mouse 
 
m
 
 chain antibody
was purchased from Southern Biotechnology Associates, Inc. and
was used in culture at 10 
 
m
 
g/ml.
 
Flow Cytometry and Cell Sorting.
 
Freshly prepared or cul-
tured lymphocytes were resuspended in FACS
 
®
 
 buffer (1% BSA,
0.05% sodium azide in PBS) at a concentration of 5 
 
3
 
 10
 
6
 
 cells/
 
ml. Three- to four-color fluorescence surface staining was done
using various combinations of FITC-, PE-, Cy5-, and Cy-
chrome™-labeled antibodies. Fluorescent-labeled anti–mouse
antibodies anti-CD4 (L3T4), anti-CD8
 
a
 
 (Ly-2), anti-CD45R/
B220 (RA3-6B2), anti-CD1 (1B1), anti-IgD (11-26c.2a), anti-
IgM R6-60.2), anti-CD69 (H1.2F3), anti-CD62L (L-selectin),
anti-CD5, anti-Fas, anti-CD23 (IgE Fc receptor), anti-CD24
(HSA, 30F1), and anti-CD21 were supplied by BD PharMingen.
Cy5-conjugated anti-IgM antibody was purchased from Jackson
ImmunoResearch Laboratories. FITC-labeled antibodies were
used diluted 1:100, whereas other fluorochrome-labeled antibod-
ies were used at a 1:200 final dilution.
 
 
 
Annexin V-FITC Apopto-
sis Detection Kit 1 (BD PharMingen) was used according to the
manufacturer’s instructions. For flow cytometry we acquired
30,000 events per sample.
For BAFF binding experiments, sorted T1 and T2 B cells were
incubated with 2 
 
m
 
g/ml of flag-tagged human BAFF for 1 h on
ice in FACS
 
®
 
 buffer. Cells were washed twice and stained with a
biotinylated anti-Flag antibody M2 (Sigma-Aldrich) diluted 1:500.
Cells were washed twice and the signal was detected using PE-
labeled streptavidin (Jackson ImmunoResearch Laboratories).
Figure 1. Survival of BAFF-treated splenocytes in vitro. C57BL/6-derived
splenocytes were cultured for 72 h with or without BAFF and analyzed
by flow cytometry on FSC/SSC plots. Gates R1 (low FSC, dead cells)
and R2 (high FSC, live cells) are indicated in each plot. (A) R1 and R2
populations in fresh and cultured splenocytes 72 h with or without BAFF.
(B) The effect of rabbit anti-BAFF, control rabbit serum, or 2 mg/ml in-
activated (boiled) BAFF on the size of the R2 population as indicated.
The slight inhibition observed with control rabbit serum is due to the
higher serum concentration in the culture and was similar to that of four
other control rabbit sera tested in this assay (data not shown). These plots
are representative of at least five experiments.
Figure 2. BAFF specifically promotes the survival of splenic B cells. (A)
Splenocytes from C57BL/6 mice were stained with antibodies to B220
and CD3. B2201 B cells and CD31 T cells were purified by cell sorting
and incubated for 72 h with BAFF (bottom) or without (top). The R1
(dead cells) and R2 (live cells) gates for sorted B cells (left) and sorted T
cells (right) are drawn. (B) Lymphocytes were prepared from spleen,
PLNs (inguinal and brachial LNs), MLNs, and PBLs, and incubated with
BAFF (black bars) or without (white bars) for 72 h. Staining with annexin
V/PI was analyzed by flow cytometry and percentages of annexin V/PI
double-negative R2-gated cells (live cells) are shown for each lymphocyte
preparation. The plots in A are a representation of three separate experi-
ments and the graph in B represents the mean and standard deviation of
six separate lymphocyte preparations. P values were obtained using analy-
sis of variance (ANOVA).
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Data were collected on a FACSCalibur™ flow cytometer and
analyzed using CELLQuest™ software (Becton Dickinson).
For cell sorting of splenic B and T cells, 5–10 
 
3
 
 10
 
8
 
 freshly
isolated splenocytes were stained with PE-labeled anti-B220 and
FITC-labeled anti-CD3 in PBS plus 10% FCS. Staining with
biotin-labeled anti-HSA (revealed using Cychrome™-labeled
streptavidin) and FITC-labeled anti-CD21 was used to sort T1
and T2 B cells instead of anti-IgM or anti-IgD to prevent poten-
tial activation signals through the BCR. The Mo-Flo cell sorter
(Cytomation) at the Microbiology and Immunology Department
of the University of New South Wales (New South Wales, Aus-
tralia) was used to sort gated B220
 
1
 
 B cells, CD4
 
1
 
 or CD8
 
1
 
 T
cells, HSA
 
hi
 
CD21
 
lo/
 
2
 
 T1 B cells, and HSA
 
hi
 
CD21
 
hi
 
 T2 B cells.
Reanalysis of sorted B or T cell populations demonstrated 
 
.
 
98%
 
purity. The purity for sorted populations of T1 and T2 B cells
was 90 and 95%, respectively.
 
Immunohistochemistry.
 
Frozen sections of spleen were sub-
jected to immunohistochemical analysis as described previously
(29). Biotin-labeled goat anti–mouse IgM antibodies and horse-
radish peroxidase–streptavidin were purchased from Jackson Im-
munoResearch Laboratories.
 
Results
 
BAFF Specifically Induces Survival of Splenic B Lymphocytes
In Vitro.
 
Previous studies (17, 18, 22, 26, 27) have sug-
gested a potential role for BAFF in B cell survival. We
Figure 3. BAFF induces sur-
vival of T2 B cells. (A) C57BL/
6-derived splenocytes were in-
cubated for 72 h with BAFF,
stained with antibodies to B220,
IgM, IgD, HSA, and L-selectin,
and analyzed by flow cytometry.
Freshly prepared C57BL/6 sple-
nocytes were stained in parallel.
For HSA and L-selectin expres-
sion, B2201 gated B cells are
shown. Histograms for fresh
splenocytes (black line) and R2-
gated BAFF-treated splenocytes
(gray line) are overlayed for
comparison. (B) Three-color
flow cytometric analysis of fresh
and R2-gated BAFF-stimulated
splenocytes from A. Cells were
stained with antibodies to IgM,
CD21, and CD23 and were sep-
arated into CD232 and CD231
cells. CD232 cells include
CD21loIgMhi T1 cells and
CD21hiIgMhi MZ B cells.
CD231 B cells include
CD21intIgMdull mature B cells
and CD21hiIgMhi T2 B cells. T1,
T2, mature, and MZ B cell pop-
ulations are indicated. (C) Four-
color flow cytometric analysis of
fresh and R2-gated BAFF-stim-
ulated splenocytes from A. Cells
were stained with antibodies to
IgM, CD21, CD23, and HSA.
Freshly prepared splenocytes
were gated on the T1, T2, and
mature B cell populations as de-
scribed in B and analyzed for the
expression of HSA. The mean
fluorescence intensity (MFI) for
HSA on gated T1, T2, and ma-
ture B cells (black bars) is com-
pared with that of R2-gated
BAFF-stimulated splenocytes
(white bar). Experiments in A,
B, and C are representative of at
least 10 animals and cultures an-
alyzed. (D) Freshly prepared
splenocytes were stained with antibodies to CD21 and HSA. CD21loHSAhi T1 and CD21hiHSAhi T2 B cells were identified (Before sort, top), sorted
(After sort, middle), and cultured for 72 h with BAFF (bottom). Cells were then analyzed by flow cytometry for the presence of surviving cells in the
R2 gate on FSC/SSC plots as indicated (bottom). R1 and R2 populations are shown. Percentages of cells in R2 are indicated. This figure is representa-
tive of six different cell sorting experiments analyzed.
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tested the survival effect of BAFF in vitro
 
 
 
by incubating
mouse splenocytes for 72 h with or without BAFF, and
made a first assessment by flow cytometry using forward
light scatter (FSC)/side light scatter (SSC) plots (Fig. 1 A).
Freshly prepared splenocytes displayed higher FSC levels
and are shown in the R2 population (Fig. 1 A, top). After
72 h in culture, untreated splenocytes died and display
lower FSC levels, shown as the R1 population (Fig. 1 A,
middle). Interestingly, many cells were detected in the live
R2 gate in 72-h cultures of BAFF-stimulated splenocytes
(Fig. 1 A, bottom). The FSC level of cells in R2 was similar
to that of fresh splenocytes analyzed at the same time using
the same instrument settings (Fig. 1 A, top and bottom).
The R2 cell population was markedly reduced when BAFF
was blocked using a blocking polyclonal rabbit anti-serum,
but not when a control rabbit serum or BAFF inactivated
by boiling was used (Fig. 1 B). We showed previously that
blocking BAFF with BCMA-Ig, but not a control Ig fusion
protein, was also able to reproduce this result (22). This
phenomenon was not blocked by polymyxin B at concen-
trations which in parallel inhibited the effect of 10 
 
m
 
g/ml
 
E. coli
 
–derived LPS on splenocytes (data not shown).
Moreover, the R2 population was also seen in BAFF-stim-
ulated LPS-hyporesponsive splenocytes from C3H/HeJ
mice (data not shown). These control experiments allowed
us to rule out the possibility of endotoxin contamination
from the 
 
E. coli
 
–derived BAFF preparation as the factor re-
sponsible for the presence of the R2 population. BAFF
alone at the concentrations used in our assays does not pro-
mote B cell proliferation (14, 15). In conclusion, treatment
of splenocytes for 72 h with BAFF specifically leads to the
presence of cells in the R2 gate, with FSC levels suggesting
that these cells might be surviving. We confirmed the via-
bility of BAFF-stimulated cells present in the R2 popula-
tion after 72 h in culture by showing that these cells were
negative for annexin V binding and propidium iodine (PI)
staining by flow cytometry (data not shown).
Cultured splenocytes were also double stained with anti-
B220 and anti-CD4, or CD8 antibodies to detect B and T
lymphocytes, respectively, by flow cytometry. The staining
showed that 80% of cells in R2 are B cells. Surviving B
cells represent 20–30% of the total BAFF-stimulated sple-
nocyte culture, whereas only 2–3% of B cells survived in
72-h cultures of nonstimulated splenocytes. Some T cells
(6.1 
 
6
 
 1.8 vs. 1.2 
 
6
 
 0.5% in controls), mainly CD4
 
1
 
 T
cells, survived in this assay; however, this effect might result
from some secondary support from surviving B cells. Evi-
dence for that lies in the fact that T cells, highly purified by
cell sorting, do not survive after 72-h stimulation with
BAFF (Fig. 2 A). In contrast, 27% of purified B cells sur-
vive upon BAFF stimulation in the same assay (Fig. 2 A).
Viability of the R2 population was always confirmed in
parallel using the annexin V/PI staining for each experi-
ment (data not shown). In conclusion, BAFF specifically
induces the survival of B lymphocytes independently of the
presence of T cells in vitro.
To test the potential survival effect of BAFF on B cells
from other lymphoid organs, we purified lymphocytes
from mouse blood (PBLs), peripheral LN (PLNs), mesen-
teric LNs (MLNs), and spleen, and incubated these cells
with or without BAFF for 72 h. Significant BAFF-induced
cell survival, as assessed by flow cytometric analysis of the
annexin V/PI staining, was observed for cultured spleno-
cytes (Fig. 2 B). Little cell survival was detected with
BAFF-treated lymphocytes from LNs compared with un-
treated controls (Fig. 2 B). Unstimulated PBLs survived
better in culture compared with lymphocytes from other
sources, and the effect of BAFF on survival of these cells
was variable but overall not highly significant (Fig. 2 B).
No BAFF-induced survival was seen in mouse BM, thy-
mus, or PBLs from human blood (data not shown). This
result indicates that BAFF induces the survival of predomi-
nantly spleen-resident B cell subpopulations in vitro.
 
BAFF Preferentially Induces the Survival of Splenic Immature
T2 B Cells.
 
The spleen contains various subpopulations
of B cells such as immature transitional B cells, which are
divided into the T1 and T2 subgroups (11). The mature B
cell subset is predominant, expressing low levels of IgM
(IgM
 
dull
 
), high levels of IgD (IgD
 
hi
 
), intermediate levels of
CD21 (CD21
 
int
 
), and low to intermediate levels of HSA
(HSA
 
lo/int
 
; reference 1). Finally, MZ B cells, localized in
the MZ, a structure delineating the red pulp from the
white pulp, like T2 B cells are IgM
 
hi
 
 and CD21
 
hi
 
 but do
not express either CD23 or IgD (30).
To define which of these B cell subpopulations survived
after stimulation with BAFF, BAFF-treated splenocytes
were stained with anti-IgM, anti-IgD, anti-B220, anti-
HSA, anti-CD23, anti-CD21, and anti–L-selectin antibod-
 
Table I.
 
Proportion of T1, T2, Mature, and MZ B Cells in 
Freshly Prepared or Cultured BAFF-treated Surviving Splenocytes
 
Fresh splenocytes
(percentage of
live gate)
BAFF-treated splenocytes
(percentage of
living pool)
 
P
 
 values
Mature 36 
 
6
 
 1.5 20 
 
6 
 
0.1
 
*
 
,
 
0.05
MZ 10 
 
6
 
 1.3 2.2 
 
6 
 
0.6
 
,
 
0.01
T1 3.2 
 
6 
 
0.4 0.7 6 0.1 ,0.01
T2 3.5 6 0.3 53 6 1.4 ,0.01
Splenocytes were isolated from C57BL/6 mice and cultured with BAFF
for 72 h. These cells as well as freshly prepared splenocytes from
C57BL/6 mice were stained in parallel with a cocktail of anti-IgM, anti-
IgD, and anti-CD21 antibodies and analyzed by flow cytometry.
Various B cell subsets were gated according to their respective
phenotype as in the legend to Fig. 3 B. The FSC versus SSC profile was
obtained for each gated B cell subset and the percentage of surviving
cells in the R2 gate is indicated for BAFF-treated splenocytes. For fresh
control splenocytes, percentage within the live gate is indicated.
*These cells are falling into the mature B cell gate based on their
IgMdullerIgD1CD21int phenotype; however, they express on average
higher levels of HSA and IgM compared with control mature B cells
and may not be considered strictly as mature (see Fig. 3, A and B, and
data not shown). Values are given as mean 6 SD and are representative
of at least 10 splenocyte cultures analyzed. P values were obtained using
ANOVA.
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ies. By flow cytometry, cells were gated on the R2 surviv-
ing population (using FSC/SSC plots) and analyzed for ex-
pression of IgM, IgD, B220, HSA, and L-selectin in
comparison with normal fresh splenic B cells, which were
analyzed at the same time using the same instrument set-
tings (Fig. 3 A). The surviving R2 B cell population con-
tained IgMhi and IgD1 cells (Fig. 3 A). These cells ex-
pressed very high levels of B220, suggesting that they were
naive B cells (Fig. 3 A). R2 surviving B cells also expressed
high levels of L-selectin, indicating that they were not T1
B cells (Fig. 3 A). Staining of control fresh splenocytes with
HSA gave rise to two separate populations (Fig. 3 A),
HSAlo/int and HSAhi cells, corresponding to mature and im-
mature B cells, respectively. Interestingly, the expression of
HSA on R2 surviving B cells was higher than that of ma-
ture B cells from fresh splenocytes, a sign of immaturity in-
dicating that surviving B cells might be immature transi-
tional B cells (Fig. 3 A).
To test this hypothesis, BAFF-treated and fresh spleno-
cytes were stained with anti-IgM, anti-CD21, and anti-
CD23 antibodies, and T1, T2, mature, and MZ B cell sub-
populations were analyzed as described previously (11).
BAFF-stimulated splenocytes were gated on the R2 surviv-
ing population (Fig. 3 B). Both fresh and R2 B cells were
gated on the CD231 and CD232 subpopulations to distin-
guish T2/mature B cells from T1/MZ B cells, respectively.
The staining showed that a large proportion of the surviv-
ing cells were T2 B cells. Almost no T1 B cells were
present after 72-h culture with BAFF (Fig. 3 B). Some sur-
vival was observed in the MZ and mature B cell compart-
ment (Fig. 3 B and Table I); however, cells falling into the
mature B cell gate also expressed higher levels of HSA and
IgM compared with control mature B cells (Fig. 3 A and
see Fig. 4 B, and Table I). Interestingly, the pattern of
IgM/CD21/CD23 expression of cells in R2 was identical
to that seen with splenocytes from CBA/N and CD452/2
mice, in which B cell maturation is arrested at the T2 B cell
stage (11). Therefore, some or all of the mature-like B cells
may in fact be T2 cells expressing slightly lower levels of
IgM. The results indicate that T2 B cells account for most
of the surviving cells in R2 when compared with fresh
splenocytes (Fig. 3 B and Table I). The same results were
Figure 4. BAFF and anti-m
antibodies promote the matura-
tion of T2 B cells in vitro. (A)
CD21intHSAlo/int mature and (B)
CD21hiHSAhi T2 B cells from
C57BL/6-derived splenocytes
were sorted and incubated with
or without BAFF at time 0 as in-
dicated. After 50 h, anti-m anti-
bodies were added to the cul-
tures, which were carried out for
an additional 22 h. Cells were
stained with antibodies to HSA,
CD21, and IgD. Anti-IgM anti-
body could not be used for stain-
ing due to interferences with
anti-m antibodies used for stimu-
lation. Mature B cells were de-
fined as HSAint/loCD21intIgD1;
T2 cells as HSAhiCD21hiIgD1;
T1 cells as HSAhiCD21loIgD2;
and MZ B cells as
HSAloCD21hiIgD2. The top
panel for each B cell subset (A
and B) shows FSC/SSC plots in-
dicating the R1 and R2 regions;
the bottom panel shows analysis
of HSA versus CD21 on cells
from the R2 surviving popula-
tion subgated on the IgD1 sub-
population. Boxes for T2 and
mature B cells are drawn. This
experiment is representative of
three separate cell sorting experi-
ments.
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obtained when the IgD1 and IgD2 subpopulations were
gated instead of the CD231 and CD232 B cells (data not
shown). Moreover, the level of HSA expression on R2
surviving B cells is similar to that of gated T2 B cells from
fresh splenocytes (Fig. 3 C).
T1 and T2 B cells were purified from normal spleno-
cytes by cell sorting and incubated with BAFF for 72 h.
Only the T2, but not the T1, B cell subset survived (Fig. 3
D) and kept their original T2 B cell phenotype (data not
shown). We analyzed by flow cytometry the level of flag-
tagged BAFF binding on the surface of sorted T1 and T2 B
cells. We observed a more intense binding of BAFF to T1
B cells compared with that to T2 B cells, yet T1 B cells do
not survive in vitro after BAFF treatment (Fig. 3 D). These
results indicate that BAFF, in vitro, supports survival of T2
and some MZ B cells but not of T1 or mature B cells
BAFF and Anti-m Antibodies Promote Differentiation of T2
B Cells into Mature B Cells In Vitro. To investigate whether
BAFF, together with signals through the BCR, may be re-
quired for maturation of T2 B cells, we designed an in vitro
maturation assay. We purified by cell sorting HSAhiCD21hi
T2 and HSAlo/intCD21int mature B cells and incubated
them for 72 h with BAFF. Due to technical limitations,
z2% of mature B cells inevitably contaminate preparations
of sorted T2 cells. Anti-m antibodies can promote prolifer-
ation of mature B cells in the presence of BAFF and can in-
terfere with analysis of our maturation assay (14–17). To
overcome this problem, we added anti-m antibodies 50 h
after T2 and mature B cell cultures were started, when
most mature B cells had already died. Cells were stained
with antibodies to HSA, CD21, and IgD to delineate pop-
ulations of mature and T2 B cells. BAFF-treated mature
splenic B cells did not survive and the addition of anti-m af-
ter 50 h of culture did not rescue these cells and did not
promote their proliferation in the presence of BAFF (Fig. 4
A). This control was important, as it indicates that the inev-
itable low level of contaminating mature B cells found in
the sorted T2 B cells will not interfere with our maturation
assay using this particular experimental format. Untreated
sorted T2 B cells died after 72 h in culture (Fig. 4 B). No
cell survival was detected in cultures of T2 cells treated
with anti-m, in contrast to treatment with BAFF, which al-
lowed T2 cells to survive (Fig. 4 B). Interestingly, in cul-
tures of sorted T2 cells incubated for 72 h with BAFF and
treated with anti-m after 50 h in culture, we detected the
presence of HSAint/lo, CD21int, and IgD1 cells correspond-
ing to the phenotype of mature B cells (Fig. 4 B). How-
ever, fewer cells were detected in the surviving R2 popula-
tion (Fig. 4 B, top) compared with BAFF treatment alone.
This possibly indicates that many T2 B cells died after anti-m
plus BAFF stimulation and only a few of them were able to
respond to the differentiating signals promoted by these re-
agents. No differentiation into MZ B cells was detected in
these assays and T1 B cells did not survive in any of the
culture conditions described here (data not shown). These
results indicate that, in vitro, BAFF can induce B cell mat-
uration when signals are triggered through the BCR of
some T2 B cells.
Elevated Numbers of T2 and MZ B Cells in the Spleen of
BAFF Tg Mice. As BAFF preferentially induces the sur-
vival of T2 and some MZ B cells from normal splenocytes
in vitro, we analyzed whether these populations were af-
fected in Tg mice overexpressing BAFF. Freshly prepared
control and BAFF Tg mice–derived splenocytes were
stained with anti-IgM, anti-CD21, and anti-CD23 anti-
bodies as described above, and subpopulations of mature,
T1, T2, and MZ B cells were analyzed by flow cytometry.
Absolute cell numbers for each B cell subset were higher in
spleens from BAFF Tg mice than from control littermates,
and reflected the splenomegaly observed in these animals
(26; Table II). However, comparison of the proportion for
each B cell subsets revealed a dominant expansion of the
T2 and MZ B cells in the spleen of BAFF Tg mice com-
pared with that of control mice (Fig. 5 A and Table II). Ex-
pansion of the MZ was also evident through histological
analysis of spleen sections stained with anti-IgM (Fig. 5 B).
In contrast, the proportion of typical mature B cells de-
creased (Table II). The proportion of T1 B cells in BAFF
Tg mice remains essentially similar to that of control sple-
nocytes (Fig. 5 A and Table II). These results were repro-
duced in another laboratory (Woodcock, S.A., Biogen In-
corporated, personal communication). Interestingly, the
level of CD21 expression on T1 B cells from BAFF Tg
mice is higher and that of IgM lower compared with levels
on T1 B cells from control spleen. Although not conclu-
sive, this observation suggests faster kinetics of B cell matu-
ration in BAFF Tg mice (Fig. 5 A).
CD1hi B cells have been shown to be the main source of
autoantibodies in a murine model of SLE (31). We ana-
Table II. Proportion of T1, T2, Mature, and MZ B Cells in the 
Spleen of Control Versus BAFF Tg Mice
T1 T2 Mature MZ
Percentage from
gated cells
Control 13 6 1.8 23 6 7.6 67 6 9.2 7.8 6 1.75
BAFF Tg 20 6 7 57 6 13 29 6 11.6 17 6 2.8
P values .0.05 ,0.01 ,0.01 ,0.01
Absolute numbers
(3106)
Control 2.1 5 17 1.6
BAFF Tg 24 75 55 54
P values ,0.01 ,0.01 ,0.05 ,0.01
Splenocytes isolated from control littermates and BAFF Tg mice were
stained in parallel with a cocktail of anti-IgM, anti-IgD, and anti-CD21
antibodies and analyzed by flow cytometry. Various B cell subsets were
gated according to their respective phenotype as in the legend to Fig. 3
B. Percentage from gated CD231 cells is shown for T2 and mature B
cells and from gated CD232 cells for T1 and MZ B cells. Corresponding
absolute numbers per spleen are also shown. Results are representative
of at least 10 animals analyzed per group. P values were obtained using
ANOVA.
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lyzed each splenic B cell subset for the presence of CD1hi B
cells in control and BAFF Tg mice. Levels of CD1 expres-
sion were generally slightly lower on B cells from BAFF Tg
mice compared with control splenocytes (Fig. 5). Interest-
ingly, in both control and BAFF Tg mice, T2 and MZ B
cells express high levels of CD1 (Fig. 5 C). However, the
CD1hi B cell compartment accounts for .30% of all sple-
nocytes in BAFF Tg mice versus only 9% in control mice
(Fig. 5 D).
We also analyzed B cells in PLNs, MLNs, and blood
from BAFF Tg mice. Few MZ-like cells could be detected
in the PBLs and PLNs of control littermates (Fig. 5 E). Sur-
prisingly, we found increased numbers of B cells displaying
a T2 and MZ phenotype in these lymphocyte preparations
(Fig. 5 E). Immaturity of the T2-like cells found in these
preparations was confirmed by their expression of HSA,
which was higher than that of gated mature B cells (data
not shown). Expression levels of L-selectin on freshly pre-
pared B cells from BAFF Tg and control mice were similar
(data not shown) and do not account for aberrant homing
of T2 and MZ B cells to the LNs. In conclusion, overex-
pression of BAFF in vivo leads to augmented numbers of
all B cells in the spleen with the preferential expansion of
the CD1hi T2 and MZ B cell compartments but also ex-
pansion of T2 and MZ-like B cells in the blood and LNs.
BAFF Tg Mice–derived Splenocytes Survive for 72 h in Nor-
mal Medium in the Absence of Exogenous Factors. Splenocytes
from control littermates were incubated in medium supple-
mented or not with BAFF. Splenocytes from BAFF Tg
mice were cultured in nonsupplemented medium. As
Figure 5. Expansion of the T2 and MZ B cell compartment in BAFF Tg mice. (A) Splenocytes freshly isolated from control littermates (Control) and
BAFF Tg mice were stained with antibodies to IgM, CD21, and CD23, and were separated into CD232 and CD231 cells. T1, T2, mature, and MZ B
cell regions were drawn as shown in Fig. 3 B. The top three histograms show all cells. Note the difference of phenotype of the T1 B cells in BAFF Tg
mice (shown with arrows), which consistently show higher CD21 levels and slightly lower IgM levels compared with control T1 splenocytes. These plots
are representative of 14 control littermates and 11 BAFF Tg mice analyzed. (B) Frozen tissue sections of spleens from a control littermate (left) and a BAFF
Tg mouse (right) were stained with biotin-labeled anti-mouse IgM and revealed using horseradish peroxidase–labeled streptavidin (brown staining). Peri-
arteriolar lymphoid sheath (PALS) or T cell zone (T) and B cell follicle (B) areas are indicated. The width of the MZ, showing a stronger IgM expression,
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shown previously, survival in control splenocyte cultures is
only apparent (R2 population) if BAFF is added to the cul-
ture (Fig. 6 A). In contrast, cultures of BAFF Tg–derived
splenocytes in nonsupplemented medium gave rise after
72 h to a surviving population of cells in the R2 gate (Fig.
6 A). Surviving cells were mainly B cells with the same
phenotype as surviving B cells after 72-h BAFF treatment
of C57BL/6-derived splenic cells (Fig. 3 A), displaying
IgMhi, IgDhi, B220hi, and HSAhi levels (Fig. 6 B), and there-
fore were mainly T2 B cells. These surviving cultured cells
also displayed higher levels of L-selectin compared with
fresh splenocytes from BAFF Tg mice (data not shown).
T2 B cells from BAFF Tg mice, isolated by cell sorting,
also survived for 72 h in vitro, indicating that the survival
status of these cells is intrinsic rather than promoted by
BAFF produced by splenic T cells in mixed cultures (data
not shown). These results suggest that T2 B cells were
“programmed/sensitized” by BAFF in vivo leading to ex-
tended, stimulation-independent survival of these cells ex
vivo.
Discussion
The mechanisms responsible for the differentiation of
immature B cells emerging from the BM into mature B
cells found in the periphery are poorly understood. It is, for
instance, still unclear why only 10% of newly formed IgM1
B cells reach the spleen, and why only a very small propor-
tion of these achieve maturation (32). Many reports indi-
cate that selection of specific transitional B cells takes place
is indicated with a black bar. These pictures are representative of at least six animals analyzed in each group. (C) Splenocytes freshly isolated from control
littermates and BAFF Tg mice were stained with antibodies to IgM, CD1, CD21, and CD23, and were separated into CD232 and CD231 cells. T1, T2,
mature, and MZ B cell regions were gated as shown in A and expression of CD1 for each B cells subset was overlayed on histogram plots. (D) A corre-
sponding graph for each histogram plot in C shows the mean fluorescence intensity (MFI) of CD1 expression on mature, T1, T2, and MZ B cells. These
results are representative of three animals analyzed per group. (E) Lymphocytes isolated as in the legend to Fig. 2 B from PLNs, MLNs, and PBLs of con-
trol littermates and BAFF Tg mice were stained and analyzed by flow cytometry for the presence of T1, T2, mature, and MZ B cells as described above
in A. Boxes indicating each B cell subset have been drawn. These plots are representative of at least six animals analyzed per group.
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during B cell maturation in the periphery, and signaling
through the BCR is a critical event in this process (11, 12,
33). Paradoxically, it is also clear that most immature transi-
tional B cells die after stimulation of their BCR, a mecha-
nism thought to eliminate autoreactive B cells (5, 6, 8, 9).
The exact nature of the positive signal driving maturation
of B cells, although unknown, is either highly specific and/
or requires concomitant signals apart from those through
the BCR to allow transitional B cells to survive and differ-
entiate into mature B cells.
We tested in vitro whether BAFF could be this extra
factor needed to push immature B cells towards survival
and differentiation. In our in vitro assays, we have been
able to demonstrate that BAFF promotes the survival of
immature T2 B cells and the differentiation of some of
them into mature B cells when anti-m antibodies were
added to trigger signals through the BCR. Therefore, in
vitro, BAFF synergizes with signals through the BCR to
promote maturation of T2 B cells and as such is a critical
new element for our understanding of this process.
The general expansion of the B cell compartment in the
spleen of BAFF Tg mice, which is characterized by in-
creased B cell numbers in all subsets, suggested that BAFF
might act on all peripheral B cells. The discrepancy of this
result with our in vitro results may be explained by envi-
ronmental/tissue-specific signals acting in association with
BAFF in vivo which the in vitro system could not mimic.
However, the vastly unequal expansion of these subsets, fa-
voring strongly the T2 and MZ B cell compartments, indi-
cated that overexpression of BAFF directly or indirectly
modified the dynamics of the entire B cell maturation and
differentiation pathway in BAFF Tg mice. These results
tend to indicate that BAFF might be a general survival fac-
tor for all B cells in vivo, with the specific potential to alter
the process of B cell maturation.
Experiments in which BCMA-Ig was used to block
BAFF in normal mice led to a marked and general reduc-
tion in B cell numbers in the periphery (22). Similarly, pre-
vious studies have shown that shutting off the expression of
the BCR on the surface of B cells led rapidly to a reduced
number of mature B cells in the periphery (34). The exact
nature of the BCR-mediated survival signal in mature B
cells is unknown. It is therefore possible that, in vivo, con-
stant signals from BAFF and through the BCR are needed
to keep the mature B cells alive. The dynamics of B cell
homeostasis are very complex, and other studies have sug-
gested that immature B cells may also compete with recir-
culating B cells for survival signals (35). We believe that
normal recirculating B cells are probably not self-renewing
and can only be replaced through the differentiation of im-
mature B cells recruited in the periphery. Therefore, inhi-
bition of BAFF, like the suppression of BCR signaling,
could also affect B cell maturation and prevent the renewal
of the mature B cell pool. 11-d treatment with BCMA-Ig
markedly (although still incompletely) reduced B cell num-
bers in the periphery (22). A longer treatment with
BCMA-Ig, reflecting the life span of recirculating B cells,
might allow most mature B cells to naturally disappear from
the periphery without being replaced. Supporting this
model, BAFF does not promote survival of naive mature B
cells, in vitro, despite expression of both BAFF receptors
on these cells (18, 22, 23). BAFF might only be an impor-
Figure 6. Immature B cells
from splenocytes isolated from
BAFF Tg mice survive in vitro
in the absence of exogenous
stimuli. Splenocytes isolated
from control littermates were
cultured for 72 h with or with-
out BAFF as indicated. Spleno-
cytes from BAFF Tg mice were
plated in parallel in normal non-
supplemented medium. The R1
and R2 populations were ana-
lyzed by flow cytometry on
FSC/SSC plots. The R1 and R2
gates are drawn on the plots. As
in the legend to Fig. 3 A, expres-
sion of B220, IgM, IgD, HSA
and L-selectin was analyzed on
control freshly prepared spleno-
cytes and BAFF Tg mice–
derived splenocytes cultured for
72 h in normal medium. Histo-
grams for fresh control spleno-
cytes (gray line indicated with an
arrowhead) and R2-gated BAFF
Tg mice–cultured splenocytes
(black line) are overlayed for
comparison.
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tant cofactor for proliferation once mature B cells have
been activated (14–18). Nevertheless, we cannot formally
exclude the possibility that, in vivo, BAFF directly supports
survival of mature B cells. Adoptive transfer of B cell sub-
sets in mice deficient for BAFF is the next strategy to ob-
tain a final confirmation on whether BAFF is a general sur-
vival factor for all B cells or a specific survival and
maturation factor for peripheral immature B cells. IL-4 and
CD40 ligand are also factors involved in B cell survival;
however, gene targeting experiments have shown that both
factors are not required for B cell maturation (36, 37).
TACI and BCMA are also the receptors for another mem-
ber of the TNF family, a proliferation-inducing ligand
(APRIL), and it is at this point unclear whether or not this
factor may also play a role in B cell survival (38).
Other intriguing features of BAFF Tg mice are the dra-
matic expansion of the MZ B cell compartment, its possible
relation with the parallel expansion of the T2 B cells com-
partment, and the autoimmune phenotype displayed in
these mice. The MZ B cell population is an obscure subset,
which contains memory as well as virgin B cells (39, 40).
Previous studies have shown that both CBA/N and
CD452/2 mice have their B cell development blocked at
the T2 B cell stage, yet these mice have a perfectly normal
population of MZ B cells (11, 41, 42). This observation led
to the hypothesis that some T2 B cells, under specific con-
ditions, may directly differentiate into MZ B cells without
going through a mature B cell stage. It is therefore conceiv-
able that in BAFF Tg mice, B cell maturation is aberrantly
skewed toward the MZ compartment. Recently, studies
using various Ig heavy chain Tg mice have shown that, de-
pending on their BCR composition, some newly formed
mature B cells could be positively selected into the MZ
compartment (40). Moreover, some B cells selected to mi-
grate to the MZ are suspected to be potentially autoreactive
(43). In addition, recent work showed that CD1hi B cells in
the spleen of NZB 3 NZW mice, a model of SLE, are the
major source of autoreactive B cells (31). We showed that
in normal mice, T2 and MZ B cells express high levels of
CD1 compared with mature and T1 B cells, confirming
previous reports (44). We also showed that the population
of CD1hi B cells is dramatically enlarged in BAFF Tg mice.
Our findings led us to a model described in Fig. 7. BAFF
promotes the survival of T2 B cells, which in normal con-
ditions will lead to the maturation of highly selected cells
into the mature follicular B cell compartment. In contrast,
in BAFF Tg mice, overexpression of BAFF may trigger ex-
cessive survival signals in T2 B cells, including autoreactive
cells, which may fail to respond to censoring death signals.
The autoreactive nature of their receptors might also force
their massive assignment to the MZ compartment and sub-
sequent expansion of this compartment, as observed in
BAFF Tg mice. These B cells may become activated by au-
toantigens at this site, contribute to the formation of nu-
merous germinal centers observed in these mice (26), and
differentiate into memory B cells, some of which may also
localize in the MZ (Fig. 7). BAFF may also be important
for the survival of germinal center B cells (28), and we do
not exclude the possibility that autoreactive B cells may also
emerge at this stage, due to aberrant survival of self-reactive
B cells created after errors during affinity maturation.
Recent work described the selective absence of MZ B
cells in PyK-2–deficient mice and a possible defect in MZ-
specific chemotaxis (45). It is also possible that BAFF stim-
ulates the production of an MZ-specific chemokine or a
chemokine receptor on B cells driving most of these cells
into the MZ of BAFF Tg mice. It is unclear whether the
presence of T2 B cells in LNs of BAFF Tg mice also re-
flects an aberrant homing process or possible BAFF-
enhanced B cell maturation in LNs. L-selectin expression
was normal on freshly isolated splenocytes from BAFF Tg
mice and cannot be evoked to explain this result. Previous
studies indicated that B cell maturation takes place in the
spleen (6, 11), yet immature B cells have also been detected
in LNs (46). B cell maturation outside of the spleen has not
been investigated, but the relatively well-sustained numbers
of B lymphocytes in splenectomized individuals raises the
question of potential alternative sites for B cell maturation.
BAFF is a pivotal survival factor during B cell matura-
tion, a process which is as yet poorly understood. Our re-
Figure 7. Proposed mecha-
nism for one origin of autoim-
mune B cells in the spleen of
BAFF Tg mice. BAFF induces
excessive survival of all B cells in
the spleen with a preferential role
on immature T2 B cells. Autore-
active T2 B cells fail to respond
to censoring death signals and
massively escape to differentiate
into CD1hi autoreactive MZ B
cells. In contact with autoanti-
gens (AutoAg), autoreactive MZ
B cells are activated and become
plasma cells or undergo affinity
maturation in a germinal center
to further differentiate into
memory B cells, some of which
will relocate into the MZ.
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sults suggest that excessive BAFF-induced survival might
induce the breakdown of immune tolerance at a critical
stage of peripheral B cell maturation. Therefore, the highly
selective recruitment of immature B cells into the mature B
cell pool might be the result of active mechanisms of self-
tolerance, possibly controlled by BAFF.
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